@article{Kumar_Thangavelu_Prabhakar_2019, title={Euglycemic diabetic ketoacidosis: another masquerader!}, volume={8}, url={https://www.ijbcp.com/index.php/ijbcp/article/view/3632}, DOI={10.18203/2319-2003.ijbcp20194283}, abstractNote={<span>Euglycemic ketoacidosis is defined by the triad of euglycemia, metabolic acidosis and ketonemia or ketonuria. In the current era of diabetic management, it is a serious concern with the usage of sodium glucose co-transporter 2 (SGLT2) inhibitors potentiated by a number of precipitating agents. Empagliflozin though a novel oral hypoglycemic agent in this category may also lead to this potential complication. Here we report a 59 year old male, type 2 diabetic who was on empagliflozin and presented with euglycemic ketoacidosis after a binge of alcohol.</span><p> </p>}, number={10}, journal={International Journal of Basic & Clinical Pharmacology}, author={Kumar, Bhargavi and Thangavelu, Saravanan and Prabhakar, Rajgokul}, year={2019}, month={Sep.}, pages={2338–2340} }